Status:
UNKNOWN
Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Premature
Thrombosis
Eligibility:
All Genders
Up to 1 years
Brief Summary
There are several factor that can be related to Neonatal Thrombotic events. Among them hypercoagulability can be the cause of those events. Factor V Leiden (FVL) and Prothrombin mutation are the most ...
Detailed Description
All the demographic and clinical data will be summarized. Factors non related to the coagulation system like catheters, severe infections or congenital heart defects will be recorded. Also a full work...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All newborns (Term and Premature) diagnosed with Neonatal Thrombotic events between year 1990 to 2010.
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01443273
Start Date
October 1 2011
End Date
December 31 2020
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit - HaEmek Medical Center
Afula, Israel, 18101